CLINICAL_TRIALS
trial_result
· 2019-06-21
Clinical Trial Update: Multiple Dose Study in Heart Failure of BAY 1067197 [Phase 2]
Summary
Phase 2 multiple-dose study of BAY 1067197 in heart failure has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Heart Failure | Phase 2 | Status: COMPLETED